Aspinall G O, Gammon D W, Sood R K, Chatterjee D, Rivoire B, Brennan P J
Department of Chemistry, York University, Toronto, Ontario, Canada.
Carbohydr Res. 1992 Dec 31;237:57-77. doi: 10.1016/s0008-6215(92)84233-i.
The pentasaccharide hapten released from the glycopeptidolipid (GPL) antigen of M. avium serovar 26 has been characterized as O-(2,4-di-O-methyl-alpha-L-fucopyranosyl)-(1-->4)- O-beta-D-glucopyranosyluronic acid-(1-->4)-O-(2-O-methyl-alpha-L-fucopyranosyl)-(1-->3)-alpha-L- rhamnopyranosyl-(1-->2)-6-deoxy-L-talose. The allyl glycosides of the outer glycosyl and glycobiosyl units of this hapten have been synthesized, the latter by a route involving oxidation of the corresponding D-glucopyranose derivative. Conjugation of allyl glycosides to protein by ozonolysis and reductive coupling afforded neoantigens (neo 26-1 and 26-2), both of which interacted with antibodies to M. avium serovar 26. The terminal sugar residue of the pentasaccharide hapten of the serovar 25 GPL had been shown to have the galacto configuration on the basis of 1H-13C NMR correlation spectroscopy, but absolute configurational assignment for the sugar awaited the synthesis, as for neo 26, of two glycobiosyl NGPs bearing the terminal sugar in the D and L enantiomeric forms, respectively. Only the glycobiosyl NGP bearing the terminal sugar as the D-enantiomer interacted with antibodies to M. avium serovar 25, thus providing evidence for the absolute configuration of the sugar, and showing that the complete oligosaccharide hapten has the structure, O-(4-acetamido-4,6-dideoxy-2-O-methyl-alpha-D- galactopyranosyl)-(1-->4)-O-beta-D-glucopyranosyluronic acid-(1-->4)-O-(2-O-methyl-alpha-L-fucopyranosyl)-(1-->3)-O-alpha-L- rhamnopyranosyl-(1-->2)-6-deoxy-L-talose.
从鸟分枝杆菌血清型26的糖肽脂(GPL)抗原释放的五糖半抗原已被鉴定为O-(2,4-二-O-甲基-α-L-呋喃岩藻糖基)-(1→4)-O-β-D-吡喃葡萄糖醛酸-(1→4)-O-(2-O-甲基-α-L-呋喃岩藻糖基)-(1→3)-α-L-鼠李吡喃糖基-(1→2)-6-脱氧-L-塔罗糖。该半抗原的外糖基和糖二糖单元的烯丙基糖苷已被合成,后者通过涉及相应D-吡喃葡萄糖衍生物氧化的路线合成。通过臭氧分解和还原偶联将烯丙基糖苷与蛋白质缀合得到新抗原(新抗原26-1和26-2),两者均与抗鸟分枝杆菌血清型26的抗体相互作用。基于1H-13C NMR相关光谱,血清型25 GPL的五糖半抗原的末端糖残基已显示具有半乳糖构型,但糖的绝对构型归属等待分别以D和L对映体形式带有末端糖的两种糖二糖NGP的合成,如同新抗原26那样。只有以D-对映体形式带有末端糖的糖二糖NGP与抗鸟分枝杆菌血清型25的抗体相互作用,从而为糖的绝对构型提供了证据,并表明完整的寡糖半抗原具有结构O-(4-乙酰氨基-4,6-二脱氧-2-O-甲基-α-D-吡喃半乳糖基)-(1→4)-O-β-D-吡喃葡萄糖醛酸-(1→4)-O-(2-O-甲基-α-L-呋喃岩藻糖基)-(1→3)-O-α-L-鼠李吡喃糖基-(1→2)-6-脱氧-L-塔罗糖。